cobalt has been researched along with sulindac in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, CH; Chen, YC; Fan, SC; Huang, CH; Liu, C; Tsai, AL; Wu, CC | 1 |
| Gan, L; Li, G; Li, J; Li, S; Liu, B; Liu, Y; Si, J; Wang, R; Zhang, B; Zhang, H; Zhang, T; Zhao, Q; Zhou, R | 1 |
2 other study(ies) available for cobalt and sulindac
| Article | Year |
|---|---|
Facilitation of human osteoblast apoptosis by sulindac and indomethacin under hypoxic injury.
Topics: Alkaline Phosphatase; Animals; Apoptosis; Aspirin; Cell Hypoxia; Cell Line, Tumor; Cell Survival; Cellular Microenvironment; Cobalt; Cyclooxygenase 2; Deferoxamine; Female; Fractures, Bone; Humans; Indomethacin; Mice; Osteoblasts; Poly(ADP-ribose) Polymerases; Sodium Salicylate; Sulindac | 2012 |
Co-SLD suppressed the growth of oral squamous cell carcinoma via disrupting mitochondrial function.
Topics: Animals; Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cobalt; Coordination Complexes; Dose-Response Relationship, Drug; Humans; Locomotion; Mitochondria; Mouth Neoplasms; Sulindac; Zebrafish | 2019 |